Skip to main content
. 2022 Jun 20;28(10):1380–1386. doi: 10.1016/j.jiac.2022.06.010

Table 4.

Differential features between the death and survival in the severe group.

Death (n = 18) Survival (n = 78) p - value
Age (median, IQR) 15.4 (3–98) 49.7 (6–120) 0.21
Male (n, %) 8 (44.4) 50 (64.1) 0.124
Underlying disease (n, %) 18 (100) 45 (57.7) <0.001
Fever (n, %) 15 (83.3) 71 (91.0) 0.39
Dyspnea/Tachypnea (n, %) 14 (77.8) 71 (91.0) 0.21
WBC > 12 k/mm3(n, %) 11 (61.1) 12 (15.4) <0.001
NEUa> 10 k/mm3(n, %) 6 (33.3) 4 (5.1) 0.003
CRP (median, IQR) 53.6 (6.6–172.2) 5.6 (0.7–41.6) 0.02
CRP > 20 mg/L (n, %) 10 (55.6) 29 (37.2) 0.152
Ferritin (median, IQR) 543.3 (287.5–837.2) 474.2 (249.6–780.5) 0.63
Elevated ferritin (n, %) 15 (83.3) 74 (94.9) 0.12
D-dimer (median, IQR) 1.7 (0.8–2.8) 1.1 (0.6–1.8) 0.04
D-dimer > 5 ULNb(n, %) 10 (55.6) 23 (29.5) 0.04
Respiratory support (n, %) 18 (100) 75 (96.2) 0.53
Anticoagulant (n, %) 10 (55.6) 73 (93.6) <0.001
Corticosteroids (n, %) 12 (66.7) 78 (100) <0.001
Remdesivir (n, %) 3 (16.7) 39 (50.0) 0.02
Antibiotics (n, %) 18 (100) 77 (98.7) 0.81
a

NEU: Neutrophil.

b

ULN: Upper Limit of Normal.